Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-99
Closed -$9.24K 131
2023
Q3
$9.24K Hold
99
0.01% 96
2023
Q2
$12.7K Buy
+99
New +$12K 0.01% 97
2022
Q1
$5K Buy
+40
New +$4.38K ﹤0.01% 119
2020
Q4
Sell
-34,564
Closed -$3.56M 108
2020
Q3
$3.56M Buy
34,564
+11,032
+47% +$1.15M 3.16% 11
2020
Q2
$2.38M Buy
+23,532
New +$2.11M 1.9% 14
2019
Q4
$1.12M Buy
20,436
+16,172
+379% +$767K 0.91% 18
2019
Q3
$159K Buy
4,264
+60
+1% +$2.33K 0.15% 70
2019
Q2
$157K Buy
+4,204
New +$132K 0.15% 74

Other funds holding DXCM

HWG Holdings's DXCM Position: Q4 2023 in Review

HWG Holdings sold out of DexCom (DXCM) in Q4 2023, closing a stake of 99 shares — an estimated $9.24K sold.

HWG Holdings first reported a position in DXCM in Q2 2019 and held it in 8 quarters. The position peaked at $3.56M in Q3 2020. 975 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • HWG Holdings reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • HWG Holdings sold 99 DexCom shares in Q4 2023, an estimated $9.24K.
  • HWG Holdings first reported a position in DexCom in Q2 2019 and held it in 8 quarters.
  • HWG Holdings's DexCom position peaked at $3.56M in Q3 2020.
  • 975 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on HWG Holdings's 13F filing for Q4 2023, filed 4 Jan 2024.